methylergometrin 0.1mg/ml rastvor za injekciju
hemofarm a.d. vrŠac p.j. podgorica - metilergometrin - rastvor za injekciju - 0.1mg/ml
sinoderm 0.25mg/g mast
galenika crna gora d.o.o. za proizvodnju i promet farmaceutskih proizvoda - fluocinolon acetonid - mast - 0.25mg/g
sinoderm n 0.25 mg/g + 3.3 mg/g krem
galenika crna gora d.o.o. za proizvodnju i promet farmaceutskih proizvoda - fluocinolon acetonid, neomicin - krem - 0.25 mg/g + 3.3 mg/g
sintopozid 100mg/5ml koncentrat za rastvor za infuziju
"evropa lek pharma" doo podgorica - etopozid - koncentrat za rastvor za infuziju - 100mg/5ml
bedoxin 20mg tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, budva - piridoksin - tableta - 20mg
forthyron flavoured, 200 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 400 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 600 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
forthyron flavoured, 800 mikrograma
eurovet animal health b.v., handelsweg 25, 5531 ae bladel, nizozemska - levotiroksinnatrij - tableta - sintetski hormoni štitne žlijezde - pasa
olumiant
eli lilly nederland b.v. - baricitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant se može koristiti kao monoterapija ili u kombinaciji s metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.